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Diversity at pathogen genetic loci can be driven by host adapt-
ive immune selection pressure and may reveal proteins impor-
tant for parasite biology. Population-based genome sequencing
of Plasmodium falciparum, the parasite responsible for the
most severe form of malaria, has highlighted two related poly-
morphic genes called dblmsp and dblmsp2, which encode Duffy
binding-like (DBL) domain-containing proteins located on the
merozoite surface but whose function remains unknown. Using
recombinant proteins and transgenic parasites, we show that
DBLMSP and DBLMSP2 directly and avidly bind human IgM
via their DBL domains. We used whole genome sequence data
from over 400 African and Asian P. falciparum isolates to show
that dblmsp and dblmsp2 exhibit extreme protein polymor-
phism in their DBL domain, withmultiple variants of twomajor
allelic classes present in every population tested. Despite this
variability, the IgMbinding functionwas retained across diverse
sequence representatives. Although this interaction did not
seem to have an effect on the ability of the parasite to invade red
blood cells, bindingofDBLMSPandDBLMSP2 to IgM inhibited
the overall immunoreactivity of these proteins to IgG from
patients who had been exposed to the parasite. This suggests
that IgM binding might mask these proteins from the host
humoral immune system.
Malaria is responsible for up to one million deaths annually
and therefore remains one of theworld’smajor health problems
(1, 2). Among the different species of Plasmodium causing
malaria in humans, Plasmodium falciparum is responsible for
the highest burden of disease. The clinical symptoms ofmalaria
are associated with the blood stage of the infection, when the
merozoite stage of the parasite recognizes, invades, and devel-
ops within human erythrocytes (3). Because merozoites are
directly exposed to circulating antibodies and passive immuni-
zation of infected children with purified immunoglobulins
from clinically immune individuals reduces parasitemia (4),
merozoite surface proteins are considered likely targets of host
immunity and therefore potential vaccine candidates (5). Con-
sistent with this, population-based P. falciparum genome
sequence analysis (6) has revealed that genes encodingmerozo-
ite surface proteins are among the most polymorphic in the
genome, with several exhibiting signatures of balancing selec-
tion, suggesting that host immune pressuremaintains the pres-
ence of multiple distinct antigenic variants (7).
dblmsp and dblmsp2 (also known as msp3.4 and msp3.8,
respectively) are twomembers of theP. falciparummsp3 family
that comprises a cluster of eight paralogous genes on chromo-
some 10. Themsp3 family encodes proteins, which are charac-
terized by the presence of an NLR(K/N)(A/G/N) motif at their
N terminus (8, 9), are secreted by the blood stage of the parasite,
and located in both the parasitophorous vacuole and on the
merozoite surface. Most proteins within this family also con-
tain a C-terminal acidic and a coiled-coil region believed to be
involved in oligomerization of the proteins (10), which form the
SPAM (secreted polymorphic antigen associated with merozo-
ites) domain (11). DBLMSP and DBLMSP2 are distinguished
from the other MSP3 family members because they contain a
Duffy binding-like (DBL)5 domain (8, 12). DBL domains are
known to bind directly to host receptors and are present in
other P. falciparum surface proteins including ligands involved
in erythrocyte invasion such as EBA175 and EBA140 (13–15)
andmembers of the PfEMP1 family, which are displayed on the
surface of the infected erythrocyte (16). Sequencing of some
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African P. falciparum strains has shown that the genetic diver-
sity in dblmsp and dblmsp2 is particularly high and concen-
trated in the region encoding the DBL domain (17–19). Clearly
identifiable orthologs of dblmsp and dblmsp2 are not present in
other Plasmodium species that infect humans, but the genome
of the chimpanzee parasite Plasmodium reichenowi encodes a
functional dblmsp gene, although dblmsp2 is a pseudogene
(19). Despite these interesting features, the function of
DBLMSP and DBLMSP2 and their role in the pathology of
malaria are unknown.
Here, we used recombinant proteins produced in mamma-
lian cells and a knock-out parasite line to show that the DBL
domains of DBLMSP and DBLMSP2 from the 3D7 strain of
P. falciparum bind avidly and directly to human IgM. Using
population-based genome sequencing and bespoke assembly
tools, we revealed widespread genetic diversity focused on the
DBL domain, with two major allelic forms of both dblmsp and
dblmsp2 observed in populations from Africa and Southeast
Asia. Despite their diversity, binding of the DBL domains from
different DBLMSP and DBLMSP2 sequence variants to human
IgMwas conserved, suggesting an important role in the parasite
biology.
Results
DBLMSP and DBLMSP2 Bind Human IgM—To gain insight
into the functional role of DBLMSP and DBLMSP2 during
malaria pathogenesis, we first expressed the entire coding
region of both proteins from the P. falciparum 3D7 strain using
a recently developed expression system based on mammalian
cells, which has been shown to produce natively folded P. fal-
ciparum proteins (20). Both proteins were expressed (Fig. 1A),
and their immunoreactivity to sera from malaria-exposed and
unexposed control individuals was quantified. To our surprise,
whereas otherMSP3 familymembers (MSP3,MSP6,H101, and
MSP11) and DBL-containing merozoite surface proteins
(EBA140, EBA175, and EBA181) reacted, as expected, with only
the exposed sera, DBLMSP and DBLMSP2 showed equally
strong immunoreactivity to both the unexposed control and
exposed sera (Fig. 1B). This suggested that recombinant
DBLMSP and DBLMSP2 bound immunoglobulins present in
normal serum from individuals without prior exposure to the
malaria parasite. Indeed, when each protein was exposed to
purified human immunoglobulin isotypes, strong binding was
observed to IgM, but not to IgA, IgE, or IgG (Fig. 1C). This
binding was specific to human IgM because they did not bind
immunoglobulins from other mammalian species including
goat, rabbit, guinea pig, and cow, or purified mouse IgM (Fig.
1D). To confirm these observations, we showed that DBLMSP-
coated beads but not control beads incubated in normal human
serum purified bands with masses there were consistent with
the heavy and light chain of IgM (Fig. 1E), and their identities
were subsequently confirmed by mass spectrometry.
IgM adopts a flat, planar structure in solution but can change
to a “staple” conformation upon antigen binding, thereby per-
mitting interaction with other proteins such as C1q (21). To
determine whether antigen bound to IgM influenced its inter-
actionwithDBLMSP andDBLMSP2,wemade use of two trans-
fectomas producing chimeric IgMs that recognize dinitrophe-
nyl but differ by either the presence or absence of a murine
J-chain. In these chimeric IgMs, the whole  light chain and the
variable region of the heavy chain are ofmurine origin, whereas
the heavy chain Fc constant region is human (22). DBLMSP and
DBLMSP2 bound IgM from both transfectomas, demonstrat-
ing that they interact with the human IgMheavy chain constant
region, and this binding was independent of whether they were
engaged with antigen or not. Binding of DBLMSP2 to IgMs
lacking a J-chain, however, was consistently weaker (Fig. 1F).
The DBL Domain of DBLMSP and DBLMSP2 Binds Directly
and Avidly to the IgM C4 Domain—To identify the region on
IgM that bound DBLMSP and DBLMSP2, we used mouse
monoclonal antibodies that bind to specific domains of the
human  chain constant region (23, 24). Antibody 1G6, whose
epitope is located within the C4 domain, inhibited the inter-
action of DBLMSP and DBLMSP2 with human IgM, whereas
antibodies IX11 and HB57, with epitopes located in the C1
and C2 domains, respectively, or the C3-specific antibodies
196.6b and 5D7 did not (Fig. 2A). To confirm these observa-
tions, we also made use of chimeric recombinant antibodies in
which domains of the human  chain constant region replace
domains from the human  or  chain (25, 26). In all cases,
binding of DBLMSP andDBLMSP2 proteins was observed only
when the C4 domain was present in the chimeric antibodies,
and no binding was detected with domain-swapped antibodies
containing only the C2 or C3 domains (Fig. 2B).
To determine which regions of DBLMSP and DBLMSP2
were involved in IgM binding, we individually expressed either
the DBL domain or the SPAM fragment. The SPAM fragments
did not bind IgM, whereas the isolated DBL domains bound
IgM as efficiently as the full-length proteins in this assay, indi-
cating that the DBL domain encompassed all IgM binding
activity (Fig. 2C).
DBLMSP and DBLMSP2 Form Multimers That Interact
Avidly withHuman IgM—To determinewhetherDBLMSP and
DBLMSP2 could, like MSP3, form oligomers, we first used size
exclusion chromatography on each full-length protein. In both
cases, polydisperse peaks were observed, suggesting the forma-
tion of higher order oligomers composed exclusively of the pro-
teins of interest (Fig. 3A). We then resolved purified proteins
encompassing the DBL domain and SPAM fragment by size
exclusion chromatography. Although the DBL domain of
DBLMSP2 eluted as a single monodisperse peak consistent
with it being a monomer, the SPAM fragment elution profile
was polydisperse, with peaks consistent with tetrameric and
other higher order complexes and only aminor fraction consis-
tent with a monomeric form (Fig. 3B). A similar analysis of
DBLMSP gave comparable results, suggesting that both
DBLMSP and DBLMSP2 are able to form higher order oligo-
mers by interactions through their C terminus.
To quantify the interaction between IgMandbothDBLMSPs
and demonstrate that the proteins interacted directly, we used
surface plasmon resonance. Binding of soluble, purified human
IgM was tested against immobilized full-length DBLMSP or
DBLMSP2, mimicking the orientation of the proteins that
would be expected in vivo. IgM binding to both parasite pro-
teins was clearly saturable, demonstrating the specificity of the
interactions,with equilibriumbinding constants (KD) of 0.3 and
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1.1 nM for DBLMSP and DBLMSP2, respectively (Fig. 3C).
Given the multimeric nature of both IgM and the two parasite
proteins studied, these measurements reflect overall binding
avidity and are not easily comparable with other monomeric
protein interactions.We therefore immobilized human IgMon
the chip and used the monomeric DBL domains as analytes.
Using this approach, the affinity for human IgM was 200–550-
fold weaker, reflecting the loss of avidity but nonetheless still
strong, with an equilibrium binding affinity of 60 nM for
DBLMSP versus 600 nM for DBLMSP2 (Fig. 3D). The physio-
logical concentration of IgM in human serum is 1–2 mg/ml
(1–2 M), which is at least 3 orders of magnitude higher than
the measured binding constants and implies that all serum-
exposed DBLMSP and DBLMSP2 would be rapidly and irre-
versibly complexed with IgM.
dblmsp-deficient Merozoites Invade Erythrocytes Efficiently
but Do Not Bind IgM—To demonstrate that native DBLMSP
could bind human IgM, we generated dblmsp P. falciparum
merozoites in which the dblmsp gene has been targeted (Fig.
4A) and confirmed this by Southern blotting (Fig. 4B). Using an
antibody raised against the SPAM region of DBLMSP, we
showed that the dblmsp parasites no longer expressed
DBLMSP protein (Fig. 4C) and that it was absent from the sur-
face of merozoites (Fig. 4D).We then used immunohistochem-
istry to test for the presence of human IgM at the surface of
3D7 wild-type or dblmsp parasites. In wild-type parasites,
DBLMSP is expressed at the surface of merozoites in all schi-
zonts, whereas DBLMSP2 is present in only a very small subset
of schizonts (1% or less) (17). Following culture in the presence
of purified human IgM or with human serum, IgM could be
FIGURE 1. Recombinant P. falciparum DBLMSP and DBLMSP2 bind human IgM. A, anti-biotin Western blot showing expression of recombinant monobi-
otinylated DBLMSP and DBLMSP2 proteins from mammalian cells. B, DBLMSP and DBLMSP2 are immunoreactive with control, naïve human sera. Enzymatically
monobiotinylated recombinant parasite proteins were immobilized on streptavidin-coated plates, and their immunoreactivity to pooled sera from either
unexposed individuals (black bars) or immune Kenyan adults (gray bars) was tested. C, DBLMSP (blue) and DBLMSP2 (red) bind purified human IgM and no other
immunoglobulin isotype, relative to no immunoglobulin control (ctl). D, DBLMSP and DBLMSP2 binding was restricted to human IgM, and did not bind sera
from other species, including purified murine IgM. E, streptavidin-coated paramagnetic beads were coated in monobiotinylated His6-tagged recombinant
DBLMSP or a control protein (Cd4-d3  4) and incubated in the presence of normal human serum. Following elution and resolution by SDS-PAGE, 80- and
25-kDa bands corresponding to the heavy (H) and light (L) chains of human IgM, respectively, were observed in the DBLMSP but not the negative control
pulldown. Purified albumin, DBLMSP, and IgM protein are shown for comparison on the left. F, both DBLMSP and DBLMSP2 bound chimeric IgM containing
human heavy chains regardless of whether it was antigen-bound (right panel) or not (left panel). Both DBLMSP and DBLMSP2 could bind IgM that contained or
lacked a J-chain, although DBLMSP2 binding to IgM lacking a J-chain was reproducibly weaker. Negative control was the Cd4 tag alone. B–D and F represent
one representative from two or more ELISA experiments; bars represent means  S.D.; n  3 replicate wells.
Human IgM Binds Broadly Diverged DBLMSP Protein Variants
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detected readily at the surface of wild-type but not dblmsp-
deficient merozoites (Fig. 5A). These observations were further
confirmed by immunoelectron microscopy of purified wild-
type and knock-out merozoites incubated in the presence of
purified human IgM,which showed regular punctate labeling at
the surface of wild-type but not dblmspmerozoites (Fig. 5B).
These data demonstrate that native DBLMSP binds IgM and is
the sole IgM-binding protein at the surface of mostmerozoites.
dblmsp knock-out mutants grown in the presence of medium
containing a serum alternative that does not contain human
IgMdid not show any invasion phenotypewhen comparedwith
the wild type. To determine whether the presence of human
IgMon themerozoite surface had any effect on the ability of the
wild-type parasite to invade red blood cells, we also performed
invasion assays with parasites grown in either serum alternative
alone or serum alternative supplemented with 1 mg/ml human
IgM. No difference in invasion efficiency was observed, sug-
gesting that the presence of human IgM on the merozoite sur-
face does not affect erythrocyte invasion in vitro (Fig. 5C).
dblmsp and dblmsp2 Are Dimorphic—Our observations sug-
gest that the DBLMSP and DBLMSP2 proteins from the 3D7
strain of P. falciparum parasite are able to bind human IgM.
Sequencing of some P. falciparum isolates from Africa has,
however, shown sequence variability in dblmsp and dblmsp2
(17–19). To further characterize the genetic diversity in these
two genes, we looked at the sequence variability among field
isolates from Africa and Southeast Asia. Characterizing and
quantifying genetic architecture in field isolates using popula-
tion-based genomic sequencing are challenging both because
of their high degree of polymorphism and the appreciable levels
of mixed infections. To circumvent these issues, we applied the
Cortex de novo variation assembler (27, 28), which constructs a
so-called de Bruijn graph representing the sequence and varia-
tion within the sample without the use of a reference genome.
This method is agnostic to different types of genetic variation
including indels and structural variants and is highly specific.
Using this method, we generated biallelic variant calls across
the P. falciparum genome using short-read Illumina sequence
data from 434 field isolates from the Gambia, Ghana, Guinea,
and Cambodia (minimum 50 coverage; mean read length, 74
bp) as reported elsewhere (17, 29, 30). Comparing genome
sequences across P. falciparum isolates revealed striking
regions of high sequence diversity, for example on chromosome
10 (Fig. 6A), and in particular around the MSP3 gene family.
Using this approach, the highest peak was observed at msp3
whose two diverged haplotypes, within which recombination is
reduced, have been verywell studied in the literature andwhose
divergence precedes the P. reichenowi/P. falciparum split (31);
however, we also observed extremely high peaks at dblmsp and
dblmsp2.
FIGURE 2. The DBL domains directly interact with the C4 domain of human IgM. A, monoclonal antibodies to human IgM with known domain-specific
epitopes were used to map the DBLMSP and DBLMSP2 binding domain on human IgM heavy chain. Binding of both parasite proteins was inhibited by the
C4-specific 1G6 antibody but not by antibodies recognizing other domains or by the IF11 antibody, which is known to bind a different epitope on C4.
Negative control was immobilized biotinylated IgG. B, DBLMSP and DBLMSP2 bound the C4 domain of human IgM. Systematic testing of a small panel of
chimeric human immunoglobulins containing different combinations of heavy chain domains from either IgA, IgG, and IgM (numbered and labeled , , and
, respectively) showed DBLMSP and DBLMSP2 bound the C4 domain only. C, the DBL domain of DBLMSP and DBLMSP2 bound human IgM. Fragments
encompassing the DBL, but not the SPAM domain, of both DBLMSP and DBLMSP2 bound human IgM indistinguishably from the full-length (FL) protein. Bars
represent means  S.D. in all panels; n  3 (A and C) or 4 (B) replicate wells.
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After close examination of the variant calls within dblmsp
and dblmsp2, we found a large number of overlapping variants.
Because Cortex only calls biallelic variants, samples with mul-
tiple infections, which contain more than two alleles at a single
site, will return no value. Because few sites were multiallelic in
all samples, we took the union of all sites in the 434 samples and
removed redundancy; this union contained the vast majority of
polymorphic sites. The overlapping alleles in dblmsp and
dblmsp2 were long (up to 1 kb) and shared sequence. As a
result of this, together with the unknown multiplicity of infec-
tion and lack of phasing information with the short Illumina
reads, we took a conservative approach and did not attempt to
genotype the implied long multiallelic variants. Applying these
approaches, we established that dblmsp and dblmsp2 each con-
FIGURE 3. DBLMSP and DBLMSP2 form oligomers and their DBL domain bind to human IgM with high affinity. A, size exclusion chromatography showing
polydisperse profile of full-length DBLMSP (left panel, blue) and DBLMSP2 (right panel, red). The indicated fractions were resolved by denaturing SDS-PAGE gel,
and the insets show that each peak is largely composed of the full-length protein. B, the SPAM fragment of DBLMSP2 induces oligomerization. Size exclusion
chromatography showed purified SPAM-Cd4 (green) was polydisperse, containing oligomers of higher molecular mass relative to DBL-Cd4 (orange) and the
Cd4 tag alone (black). The predicted monomeric molecular mass of SPAM-Cd4 is 52 kDa: the major peak lies within the void volume of the column used,
whereas the other two peaks correspond to theoretical molecular masses of 480 and 200 kDa, respectively. Molecular markers shown in blue are thyro-
globulin (669), ferritin (440), aldolase (158), conalbumin (75), and carbonic anhydrase (29). C, DBLMSP and DBLMSP2 bind directly and avidly to human IgM.
Equilibrium binding analysis of full-length DBLMSP (blue) and DBLMSP2 (red) to human IgM, as determined by surface plasmon resonance. Biotinylated
DBLMSP or DBLMSP2 were immobilized on a streptavidin-coated chip, and 2-fold serial dilutions of human IgM were used as analyte until equilibrium was
reached. Reference-subtracted data were plotted, and the KD values estimated by fitting to a simple Langmuir binding isotherm. D, surface plasmon resonance
was used to quantify the biophysical parameters of the monomeric DBL domains of DBLMSP and DBLMSP2 binding to human IgM. Increasing concentrations
of purified DBL domains for both DBLMSP (blue, left panel) and DBLMSP2 (red, right panel) were injected as analytes over immobilized human IgM on a sensor
chip until equilibrium had been reached (see inset). Reference-subtracted binding data were plotted as a function of injected DBL protein concentration, and
the KD values were estimated by fitting to a simple (1:1 binding) Langmuir binding isotherm. Binding of both DBL domains showed clear evidence of saturation
demonstrating the specificity of the interaction. The DBL domain of DBLMSP reproducibly bound with 10-fold higher affinity than DBLMSP2.
Human IgM Binds Broadly Diverged DBLMSP Protein Variants
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tained one major cluster of long non-recombining haplotypes
(15 haplotypes in dblmsp and 41 in dblmsp2), with differing
lengths (570 bp in dblmsp and 1350 bp in dblmsp2) and all
overlapping the region encoding the DBL domain. In dblmsp,
these 15 haplotypes grouped into two major allelic forms that
we termed class 1 (3 haplotypes) and 2 (12 haplotypes) (Fig. 6, B
and C). In dblmsp2, we found twomajor allelic forms, class 1 (6
haplotypes) and class 2 (35 haplotypes), which we subdivided
into two subclasses (c2.1 and c2.2) on the basis of multiple
sequence alignments (Fig. 6, B and D). To quantify the diver-
gence between haplotypes, we designated d(c1,c2) as the mean
number of SNP and indel differences between classes c1 and c2.
For dblmsp, d(c1,c1)  1.77 and d(c2,c2)  22.5, whereas
d(c1,c2)  185. Similarly for dblmsp2, d(c1,c1)  2.9,
d(c2.1,c2.1)  34.2, d(c2.2,c2.2)  7.0, and d(c2.1, c2.2)  61,
whereas d(c1, c2.1)  239 and d(c1,c2.2)  194, demonstrating
FIGURE 4. Generation of dblmsp knock-out parasites. A, schematic representation of knock-out strategy for dblmsp. B, Southern blot on EcoRV/BglII-digested
genomic DNA from wild-type and transgenic parasites: genomic DNA was extracted from P. falciparum 3D7 wild-type parasites, transgenic parasites in
presence of WR99210 with or without ganciclovir, and clonal transfectants as indicated are the top of the blot. Bands corresponding to the endogenous gene,
episome, and disrupted gene locus are indicated with arrows. Size markers are given on the left of the panel (in kb). C, Western blot analysis from the lysate of
1  106 schizonts prepared in SDS reducing sample buffer and incubated with the corresponding primary antibodies. DBLMSP could readily be detected in the
lysate of wild-type parasites, but not of clones A and B. Sizes of molecular mass markers (kDa) are shown on the left of the panels. D, indirect immunofluores-
cence assay on thin smears of schizont and merozoites from wild-type and dblmsp parasites showing expression of DBLMSP (green, first panel) and MSP1 (red,
second panel). The third panel depicts the overlay of both antibodies with the nuclear stain DAPI; the fourth panel shows the corresponding brightfield images.
Scale bars represent 1 m.
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that for both genes, the two main allelic classes were deeply
diverged.
To get an estimate of population frequencies, we used the
alignments to find sequence markers characteristic of the main
classes and then queried the de Bruijn graph for all 434 samples
to see which samples showed evidence of class 1 and/or class 2
haplotypes. Using this approach, we were able to find evidence
for a haplotype from either dimorphic form even in samples
where no call had beenmade. Our findings confirmed that both
dimorphic forms co-existed at high frequencies in each gene
and all four countries (Fig. 6E). Haplotype classes in all 434
samples were clearly identified in the region encoding the DBL
domain, with SNP and indel sites present on either side. Out-
side the DBL domain, a strong long range linkage disequilib-
rium structure was observed, but all four countries showed dif-
ferent patterns. Within the DBL domain, however, samples
from all countries showed both allelic classes at appreciable
frequencies, a powerful signal of balancing selection. Although
this had been shown previously in Africa, to our knowledge this
is the first time it has been demonstrated in Southeast Asia. In
the case of dblmsp, one of the two haplotype classes was very
close to the P. reichenowi sequence (Fig. 6C) and is a strong
example of balancing selection. Until further samples of
P. reichenowi are sequenced, we will not know whether the
selection pressure is present in P. falciparum only or whether
this is a trans-species polymorphism (32). Interestingly, the
population counts for haplotype classes in dblmsp showed
much higher levels of mixed infection than expected (Fig. 6E),
from which we inferred the existence of a dblmsp paralog, as
has been suggested before (19). In conclusion, the lack of
recombination within the class-defining region of the DBL
domain and the long range linkage disequilibrium observed on
either side of this region are striking and provide convincing
evidence for strong selection pressure on the DBL domains of
DBLMSP and DBLMSP2, suggesting they play an important
role in parasite biology.
Most Naturally Occurring DBL Domain Variants Can Bind
Human IgM—Because the genetic variability within dblmsp
and dblmsp2 is concentrated on the region encoding the DBL
domain, we tested whether the ability to bind IgMwas retained
across DBL sequence variants representing the major allelic
forms for both genes found in our and others’ analyses (18, 19).
For DBLMSP, a total of 10 DBL variants from 3 P. falciparum
laboratory strains: 7G8, Dd2, and FCR3; 6 field isolates; and the
P. reichenowi ortholog sharing between 59 and 99% sequence
identity were selected (supplemental Fig. S1). Except for the
DBL domains from 7G8 and 028, IgM binding was conserved
across all variants, including the most divergent (384 and
P. reichenowi) (Fig. 7A). Similarly for DBLMSP2, seven repre-
sentative DBL variants with sequence identities ranging from
62 to 98% were selected (supplemental Fig. S1). Although vari-
ant 082 repeatedly did not produce protein, all the other six
bound human IgM (Fig. 7A). Interestingly, whereas the 7G8
and 028 DBLMSP DBL domains could not bind human IgM,
their shared DBLMSP2 DBL sequence was able to do so.
To further confirm that binding to IgM was conserved
among sequence variants, we performed IgM pulldown from
long term parasite culture supernatants from the var1 and
var13 substrains of the IT4 strain (whose dblmsp sequence is
identical to that of FCR3) grown in the presence of human
serum. Following SDS-PAGE and incubation with an anti-
DBLMSP antibody, a band corresponding to the DBLMSP pro-
tein was identified in the immunoprecipitates from parasite
cultures but not from the negative control supernatant, in
which no parasite was grown (Fig. 7B). In summary, despite
their high level of sequence polymorphism, binding of the DBL
FIGURE 5. Human IgM bind native DBLMSP protein. A, indirect immunofluorescence assay for detection of human IgM was conducted on live wild-type and
dblmsp merozoites grown in either 20% human serum (HS) or 0.125 mg/ml purified human IgM (IgM). Alexa Fluor 488 goat anti-human IgM  chain
antibodies are depicted in green in panel 1. Panel 2 corresponds to the bright field image, and panel 3 shows the overlay. B, immunoelectron microscopy
showing the presence of human IgM at the surface of wild-type but not dblmsp purified merozoites. Scale bar represents 200 nm. C, addition of 1 mg/ml
purified human IgM to both wild-type and dblmsp parasites grown in Albumax did not affect their ability to infect red blood cells. Bars represent means  S.D.;
n  3 replicate wells. A representative of four independent experiments is presented.
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domains to human IgM was conserved across most of the
DBLMSP and DBLMSP2 DBL domain variants tested.
Binding of Human IgM to Their DBL Domains Masks
DBLMSP and DBLMSP2 from Host Antibodies—The fact that
the DBL domains of DBLMSP and DBLMSP2 retain IgM bind-
ing despite their extraordinary sequence diversity suggests that
DBLMSP and DBLMSP2 are targeted by the host immune sys-
tem and that IgMbinding promotes parasite survival. To deter-
mine whether individuals regularly exposed to P. falciparum
mount an immune response to DBLMSP and DBLMSP2, we
compared the immunoreactivity of the full-length proteins and
DBL domains of both DBLMSP and DBLMSP2 from the 3D7
strain to purified IgG from Malawian immune adults (33). As
comparators, we used AMA1 and RH5, which have previously
been shown to be highly and weakly immunoreactive, respec-
tively, to antibodies in sera from Kenyan, Malian, and Senegal-
ese immune adults (20, 34–36). In the absence of human IgM,
the immunoreactivity of the full-length 3D7 isoform of
DBLMSP was intermediate, being weaker than the immunore-
activity of AMA1 but significantly higher than that of RH5.
Full-length DBLMSP2, however, was only very slightly immu-
noreactive when comparedwith RH5 (Fig. 8A). Consistent with
the large number of variants observed in P. falciparum popula-
tions, almost no binding of purified hyperimmune IgG was
observed to either of the twoDBLdomains. To confirm thiswas
not merely because the sera were collected from individuals
who had not been exposed to the 3D7 variants used in this
assay, we also tested the immunoreactivity of other DBL vari-
ants for DBLMSP andDBLMSP2 and confirmed that they were
generally not immunoreactive (Fig. 8B).
Non-immune human IgM is also known to bind to some
P. falciparum PfEMP1 variants expressed at the surface of
infected erythrocytes, which are associated with rosetting or
placental malaria (24, 37). Although the function of IgM bind-
ing in rosetting remains unclear, association to the var2CSA
variant responsible for placental malaria has been linked to
masking of the parasite from antigen-specific IgG (38, 39). To
determine whether binding of IgM to the DBL domains of
DBLMSP and DBLMSP2 could have a steric immunological
“masking” effect, we precomplexed each of the two parasite
proteins with varying concentrations of purified human IgM
before incubating them with purified hyperimmune IgG. The
presence of IgM significantly reduced the overall immunoreac-
tivity of both full-length proteins in a dose-dependent manner,
an effect that was not observed for AMA1 and RH5 (Fig. 8A).
Interestingly, the presence of IgM had almost no effect on the
already very limited immunoreactivity of the DBL domains.
This suggests that binding of IgM to DBLMSP and DBLMSP2
masks antibody epitopes that are located in other regions of the
proteins.
FIGURE 6. Genome sequencing of 434 P. falciparum isolates reveals dblmsp and dblmsp2 are dimorphic and divergent. A, the number of segregating
sites across chromosome 10 from 434 P. falciparum isolates sequenced from the Gambia, Ghana, Guinea, and Cambodia, plotted in half-overlapping 500-bp
windows showing isolated regions of high sequence diversity. B, cluster dendrogram of the 15 dblmsp haplotypes (left) and 41 dblmsp2 haplotypes (right)
identified in the study. Both trees were obtained using ClustalW. C, a schematic representation of the amino acid multiple sequence alignment of six
representative exemplar haplotypes for the DBL domain of DBLMSP between residues Cys144 and Arg344, and the P. reichenowi ortholog. Note the long
non-recombining region has two alternate allelic forms (orange and yellow), of which the yellow is relatively close to the P. reichenowi sequence (shown in
brown). A phylogenetic tree indicating the relationships of the sequences built by clustering haplotypes based on a distance matrix (where distance corre-
sponds to the number of SNP and indel differences) is shown on the left. D, a schematic representation of the amino acid multiple sequence alignment of 10
representative exemplar haplotypes for the DBL domain of DBLMSP2 between residues Glu102 and Gly550. Note the long non-recombining region has two
alternate allelic forms (orange for class 1 and purple/dark green for subclasses 2.1/2.2, respectively). A phylogenetic tree indicating the relationships of the
sequences built by clustering haplotypes based on a distance matrix (where distance corresponds to the number of SNP and indel differences) is shown on the
left. E, haplotype structure in the region of DBLMSP; rows are samples, and columns are polymorphic sites. Outside the DBL domain, the reference allele is shown
in red, the alternate allele is in blue, and missing data are in white. Within the DBL domain, the class of allele found in each sample is shown: class1 only (yellow),
class 2 only (green), or both present (black). Samples are split by country and then sorted first by DBLMSP type and then by haplotype structure outside the DBL
domain. Note that the x axis is not drawn to scale.
FIGURE 7. Binding to human IgM is conserved across DBLMSP and DBLMSP2 variants. A, IgM binding to representative DBL domains from 11 DBLMSP
(blue) and seven DBLMSP2 (red) was conserved. Only the DBLMSP DBL domains from the laboratory strain 7G8 and isolate 028 did not show binding. A
representative from two experiments is shown in each panel. Bars represent means  S.D.; n  3 replicate wells. reich, P. reichenowi. B, Western blot showing
that DBLMSP is associated to human IgM that were purified from long term cultures of IT4 var1 or var13 parasite; the negative (neg) control corresponds to
culture medium without parasites. Note that the anti-rabbit secondary antibody used in this experiment cross-reacts with the light (25 kDa) and heavy chains
(50 kDa) of human IgG.
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Discussion
The deeply diverged lineages preserved in dblmsp and
dblmsp2 across P. falciparum populations suggests that they
are under extremely strong selection and must have important
biological functions. One possibility is that they are direct tar-
gets of the host immune response and are therefore potential
targets for therapeutic intervention, but their function has
remained unknown. Here, we have demonstrated that the DBL
domains in both proteins bind directly and avidly to host IgM
and that this function is conserved between the different
sequence variants identified in P. falciparum isolates.
The population-based sequence analysis of dblmsp and
dblmsp2 reported here extends earlier findings that both genes
exhibit a strong allelic dimorphism with limited interallelic
recombination across parasite isolates from all populations
sampled. Strikingly, we have now shown that both allelic classes
in dblmsp and dblmsp2 are present at relatively high frequency
in populations from West Africa (Ghana, the Gambia, and
Guinea) and Southeast Asia (Cambodia), with recombination
absent (or selected against) within a specific block of the DBL
domain. The pattern of balancing selection preserving two
deeply diverged haplotypes with reduced recombination has
FIGURE 8. IgM binding to full-length DBLMSP and DBLMSP2 masks them from the host immune system. A, normalized amounts of full-length (FL)
DBLMSP, DBLMSP2, RH5, the entire ectodomains of AMA1, or the DBL domain of both DBLMSP and DBLMSP2 expressed as -lactamase-tagged pentamers
were precomplexed with varying concentrations of human IgM, and the immunoreactivity of the complexes to purified IgG from Malawian adults quantified
by -lactamase substrate hydrolysis. The immunoreactivity of full-length DBLMSP and DBLMSP2 decreased with increasing concentrations of IgM. The AMA1
and RH5 proteins were used as exemplars of high and low immunoreactivity, respectively, and their immunoreactivity, as well as those of the DBL domains, was
only marginally affected by the presence of IgM. *, 0.02  p  0.05; **, 0.01  p  0.02; ***, p  0.01; two-tailed paired t test. Shown is one representative of three
experiments. Bars represent means  S.D.; n  3 replicate wells; all proteins were the 3D7 strain sequences. B, DBL domains from a representative panel of
DBLMSP and DBLMSP2 variants were expressed as -lactamase pentamers and precomplexed with varying concentrations of human IgM before incubating
with purified immobilized IgG from Malawian adults. The immunoreactivity of all the DBL domains was very low, irrespective of the IgM concentration. The
entire ectodomains of AMA1 and RH5 from the 3D7 strain were used as exemplars of high and low immunoreactivity, respectively. Bars represent means  S.D.;
n  3 replicate wells.
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previously been seen in msp3, which lacks a DBL domain. We
would draw a distinction between this pattern, and the known
dimorphism at EBA175, which is simply a single indel, rather
than a long preserved haplotype. This unusual genetic architec-
ture raises the question as to how this dimorphism arose and is
maintained within the population. Following our demonstra-
tion that the DBL domain can bind host IgM, one possibility is
that there is a selective advantage to binding the twomajor IgM
species that either contain or lack a J-chain. Dimorphism, how-
ever, is also observed in genes encoding othermerozoite surface
proteins, suggesting selection by a broader dichotomous fea-
ture within the immune system of the host population.
Despite the large number of polymorphisms within the DBL
domains of both DBLMSP and DBLMSP2, the ability to bind
the constant region of human IgM was broadly conserved
across representative sequence variants, suggesting that this
interaction plays an important role in the parasite biology.
Using the known crystal structure of the DBL domain for
DBLMSP2 (9) to model the DBL domains of DBLMSP and
DBLMSP2 used in our functional analysis, we observed that the
majority of the differences between IgMbinders and non-bind-
ers are located in helices h1, h2a, and h4 (supplemental Fig. S2).
These helices could therefore be potential binding sites for
human IgM. Although DBLMSP is highly expressed in all
mature schizonts in the parasitophorous vacuole and located
on themerozoite surface,DBLMSP2 is only expressed in a small
percentage of schizonts (17, 40). One suggestion could there-
fore be that DBLMSP2 is expressed at the surface of the minor-
ity of merozoites committed to gametocytogenesis. One inter-
esting observation was that although all tested DBLMSP2
variants were able to bind IgM, someDBLMSP variants did not.
Although this may indicate that dblmsp function—or its ability
to bind IgM—is dispensable, which may be consistent with an
earlier finding that some dblmsp sequences from field isolates
contained premature stop codons (18, 19), 3 of 14 cloned P. fal-
ciparum lines were found to contain multiple sequences for
dblmsp (19). These results, combined with our observation of a
higher proportion than expected of mixed haplotypes at the
dblmsp locus, suggest the existence of functional paralogous
dblmsp genes that can substitute in some isolates and strains.
Our finding that DBLMSP binds to IgM with a KD almost 4
orders of magnitude lower than physiological plasma IgM con-
centrations demonstrates that DBLMSP would rapidly and
irreversibly be saturated with host IgM once merozoites are
exposed to host blood following schizont rupture. Conse-
quently, plasma-exposed DBLMSP should really be considered
as a DBLMSP-IgM complex: something thatmust be taken into
account when investigating the role of these proteins in the
blood stages of the parasite. Previous research has suggested a
role for DBLMSP in erythrocyte invasion, supported by the
presence of a DBL domain, which is shared by other invasion
ligands and its localization to the surface of merozoites (9, 40,
41), through its interaction withMSP1 (42, 43). However, addi-
tion of anti-DBLMSP antibodies at very high concentration (20
mg/ml) only had a modest 25% decrease on invasion (41), and
deletion of the dblmsp gene in the 3D7 laboratory strain did not
affect the invasion efficiency of the parasite in our study and
others (41). The presence of human IgM in the parasite culture
did not either affect the ability of wild-type or dblmsp para-
sites to invade red blood cells, suggesting that DBLMSP is not
essentially required for parasite invasion in vitro.
DBL domains, in addition to binding erythrocyte receptors
from the glycophorin family, are known to mediate IgM bind-
ing in some PfEMP1 variants that are displayed on the surface
of infected erythrocytes (37, 44–46). This IgM binding, which
is involved in adhesion of infected erythrocytes (47, 48), has
recently been suggested to cluster PfEMP1 on the erythrocyte
surface thereby increasing their avidity for host receptors (49,
50). Alternatively, PfEMP1-mediated IgMbinding could also be
implicated in masking from immune IgG, thereby acting as a
steric shield from the host adaptive immune system (38). The
conservation of IgM binding to DBLMSP, despite high levels of
sequence polymorphism, suggests it might be an important
immune evasion strategy for the parasite. Consistent with this,
a comparative immunoreactivity analysis performed with puri-
fied IgG fromMalawian adults revealed that theDBL variants of
DBLMSP and DBLMSP2 are poorly immunogenic and that
binding to human IgM further decreases the overall immuno-
reactivity to the full-length proteins. This masking, however,
did not seem to affect the accessibility of IgGs to other mero-
zoite surface proteins because surface labeling of PfMSP1 from
3D7 parasites grown in the presence or absence of human IgM
looked similar by immunofluorescence analysis (data not
shown). Binding of host IgM to DBLMSP andDBLMSP2might
thereforemask specific domains that are important for the par-
asite biology on these two proteins but whose function remains
unknown.
In conclusion, we have extended the genetic characterization
of two P. falciparum genes that are under strong balancing
selection and shown that the proteins both bind directly and
with high affinity to host IgM and thereby shield the parasite
from the host adaptive immune response. Given that both
infected erythrocytes andmerozoites are able to bind host IgM,
IgM-binding proteins could be a general immunoprotective
mechanism used by P. falciparum and possibly other parasites
and pathogens.
Experimental Procedures
Ethics Statement—Use of erythrocytes and serum from
human donors for P. falciparum culture was approved by the
National Health Service Cambridgeshire 4 Research Ethics
Committee. All subjects provided written informed consent.
The use of animals to raise antisera was performed according to
UK Home Office governmental regulations and in accordance
with European directive 2010/63/EU regarding the use of labo-
ratory animals. Research was approved by the Sanger Institute
Animal Welfare and Ethical Review Board.
P. falciparum Population Sequence Analysis—434 samples
from Gambian, Ghanaian, Guinean, and Cambodian origin
sequenced by the MalariaGEN consortium underwent stan-
dard QC protocols as previously documented (29) and were
sequenced to a depth of at least 50 with Illumina reads (mean
read length, 74 bp) and PCR-based library preparation. Samples
underwent Cortex assembly using the “Independent workflow”
as previously described (28) using a k-mer of 31. All variants
called within dblmsp and dblmsp2 were collated and clustered
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into groups separated by at least 31 bp, revealing 15 different
haplotypes overlapping the DBL domain in dblmsp and 41 in
dblmsp2. TheGenBankTM accession numbers are KM577604–
KM577618 for dblmsp and KM589600–KM589640 for
dblmsp2.
Recombinant Protein Production—All P. falciparum proteins
were produced recombinantly by transient transfection of
HEK293E cells (51) essentially as described (20) except Py
MSP119 (52). Briefly, chemically synthesized geneswere codon-
optimized for mammalian expression and cloned in frame with
an exogenous signal peptide (53), and potentialN-linked glyco-
sylation sequons were mutated to prevent inappropriate glyco-
sylation of Plasmodium proteins. All recombinant proteins
contain a C-terminal Cd4d3  4 tag (54) followed by either an
enzymatically biotinylatable sequence, a His6 tag, or a pentam-
erization sequence followed by-lactamase (55).Monobiotiny-
lated proteins were produced by cotransfecting with a plasmid
encoding secreted BirA (55, 56). Proteins were processed and
purified using His-Trap purification columns (GE Healthcare)
as previously described (57, 58).
Protein Purification from Human Serum or Parasite Cul-
ture Supernatant—Streptavidin-coated paramagnetic beads
(100 l, 1 m diameter; Life Technologies) were saturated
with 20 g of enzymatically monobiotinylated DBLMSP or a
Cd4 tag-alone control, isolated with a magnet, and washed
three times with PBS before incubating with 1 ml of filtered
human serum (Sigma) for one h at 4 °C. Beads were washed
four times with 1ml of PBS and eluted with 200 l of 1% SDS.
20 l were resolved by SDS-PAGE under reducing condi-
tions and stained with SYPRO Orange (Sigma), and the gel
image captured on a Typhoon 9400 phosphorimaging device
(GE Healthcare).
Anti-human IgM agarose beads (Sigma) were incubatedwith
long term parasite culture supernatants from the IT4 var1 and
var13 strains grown in the presence of human serum or control
culture medium without parasite for 1 week at 37 °C. After five
washes in PBS, the beads were resuspended in loading buffer in
the presence or absence of DTT, and eluates were blotted onto
nitrocellulose membranes (Amersham Biosciences Protran)
followed by blocking in PBS, 0.1% Tween 20, 5% nonfat milk
powder) and incubated for 1 h with a rabbit anti-full-length
DBLMSP antibody at a 1:100 dilution. After further washes, the
membrane was incubated with an anti-rabbit HRP-conjugated
IgG secondary antibody (1:1000; Sigma) and developed using
3	,3	-diaminobenzidine (DAKO) according to the manufactu-
rer’s instructions.
Parasite Culture and Transfection—P. falciparum parasites
(3D7 strain) were grown in vitro in RPMI 1640 medium con-
taining Albumax II or 10% human serum as described previ-
ously (59) and transfected using standard protocols (60). Trans-
fected parasite cultures were selected with 10 nM WR99210
(kind gift of Jacobus Pharmaceuticals) and 10 M ganciclovir
(Sigma-Aldrich) and cloned by limiting dilution.
dblmsp Knock-out Construct Design and Characterization—
For gene disruption via double homologous recombination in
P. falciparum, a 520-bp 5	 fragment (F1 region) and a 659-bp 3	
fragment (F2 region) comprising ORF and UTR sequences of
dblmsp were amplified using primers 348F1for (5	-AATAAA-
CCGCGGCACATTTAATTAAGGTTGTATTTACTG-3	, SacII
site underlined), 348F1rev (5	-TTATTTAGATCTGACATT-
TTTAATACCCTTACAAAAATTTTC-3	; BglII site under-
lined), 348F2for (5	-TTATTTATCGATAGTGTTAGGGAT-
TCTAGTAATCTAGATCAACG-3	; ClaI site underlined),
and 348F2rev (5	-TTTATTCCTAGGCATATCTTCTGTCA-
AACCCTTAAAAATAGTTTC-3	; AvrII site underlined).
Amplification products were digested using SacII  BglII (F1
flank) and ClaIAvrII (F2 flank) and cloned into pHTK vector
(60), resulting in construct pHTKDBLMSP.
For Southern blotting, the genomic DNA from P. falciparum
3D7 wild-type parasites, transgenic parasites in presence of
WR99210 with or without ganciclovir, and clonal transfectants
were digested with EcoRV and BglII, separated on a 0.7% aga-
rose gel, and transferred onto a nitrocellulose membrane using
standard techniques. A radioactive probe was generated from
the 520-bp F1 flank in construct pHTKDBLMSP using ran-
dom priming (Decaprime II; Ambion). Hybridization was
carried out at 62 °C overnight before stringent washes and
autoradiography.
ForWestern blot analysis, total lysate from 1 106 schizonts
was prepared in SDS reducing sample buffer and boiled at 95 °C
for 5 min. The lysates were separated on precast 10% Bis Tris
NuPAGE polyacrylamide gels (Invitrogen) and transferred to
nitrocellulose membranes by electroblotting. The membranes
were blocked and incubated with rabbit anti-DBLMSPSPAM
(1:2000), rabbit anti-MSP3 (1:2000),mouse anti-MSP2 (1:1000)
(61), and rat anti-BiP antibodies (1:1000). Bound antibodies
were detectedwith horseradish peroxidase-conjugated second-
ary antibodies (Bio-Rad).
For immunofluorescence analysis, thin smears of schizont
and merozoites from wild-type and dblmsp parasites were
incubated with anti-DBLMSPSPAM (1:2000) and anti-MSP119
(clone 1E1, 1:3000) antibodies diluted in 3%BSA/PBS and incu-
bated for 1 h at room temperature before washes and incuba-
tion with secondary Alexa Fluor-labeled (488 and 594; Invitro-
gen) antibodies at 1:5000.
Human IgM Binding to Merozoites—To detect IgM binding
to merozoites, parasites were tightly synchronized before late
stage schizonts were purified using 70% Percoll, put back into
culture containing RPMI  Albumax II with the addition of
20% human serum or 0.125 mg/ml purified human IgM
(Sigma). IgM was detected using an Alexa Fluor 488 goat anti-
human IgM  chain antibody (Molecular Probes; preadsorbed
against human IgG) at 1:1000. The slideswere viewed on aZeiss
Axioplan 2 imaging systemwith PlanApochromat 100/1.4 oil
immersion objective. Images were captured using Axiovision
4.6.3 software and edited using Adobe Photoshop.
For immunogold labeling, merozoites were fixed in 4% para-
formaldehyde in 0.1 M phosphate buffer at pH 7.4 for 1 h at
room temperature, rinsed three times in buffer, and infiltrated
with 1% and then 10% gelatin before immersing in 2.3 M
sucrose in phosphate buffer overnight at 4 °C for cryoprotec-
tion. Frozen samples were prepared by mounting onto alu-
minum pins and rapidly immersing in liquid nitrogen in
preparation for ultrathin 80 nm sectioning on a Leica EM
FC6 ultramicrotome. Ultra thin sections were labeled as per
Tokuyasu (62), with a rabbit anti-human IgM antiserum
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(Abcam) diluted 1:25, and detected with 10-nm protein A
gold. Imaging was performed on an FEI 120kV Spirit Biotwin
with a Tietz F4.15 CCD camera.
Cell Culture of Transfectomas Secreting Anti-dinitrophenyl
Human IgM—Transfectomas expressing anti-dinitrophenyl
IgM antibodies containing the human constant heavy chains
either with (Xp) or without (Gp) the mouse J-chain (22) were a
kind gift of Prof. Marc Shulman. Transfectomas were grown in
DMEM supplemented with 10% fetal bovine serum, 0.6 mg/ml
G418, and 0.02% -mercaptoethanol, and supernatants were
harvested and filtered before use in ELISA and AVEXIS
experiments.
ELISA and Primary Antibodies—Biotinylated recombinant
P. falciparum proteins were normalized and immobilized on
streptavidin-coated plates, preblocked with HBS and 0.1%
Tween 20 (HBST), 2% BSA for 30 min. After washing with
HBST, serial dilutions of either pooled human sera from 10
malaria-exposed or malaria-naïve individuals, transfectoma
cell culture supernatants, or purified primary antibodies were
incubated for 90min. The plateswere againwashedwithHBST,
and appropriate alkaline phosphatase-conjugated secondary
antibodies were incubated for 1 h. The plates were washed with
HBST and once with HBS before adding p-nitrophenyl at 1
mg/ml, and absorbance at 405 nm was quantified on either a
PHERAstar Plus or FLUOstar Optima plate reader (BMG
Labtech). For domainmapping experiments involving chimeric
human antibodies, an HRP-conjugated anti-human secondary
antibody was used. Following PBS washes, tetramethylbenzi-
dine substrate was added, and absorbancewas quantified at 450
nm. All procedures were performed at room temperature. Pri-
mary antibodies used were: anti-Cd4OX68 (1:1000; AbD Sero-
tec); purified human IgA, IgE, IgM (3 g/ml; Sigma), or IgG (3
g/ml; Bethyl Laboratories); human, goat, rabbit, guinea pig, or
bovine serum (1:1000; Sigma); purified mouse IgM (10 g/ml
MEM-150; Abcam); or domain-swapped human antibodies at
25 nM (25, 26). All alkaline-phosphatase-conjugated secondary
antibodies were from Sigma, except anti-rabbit immunoglobu-
lins (Jackson ImmunoResearch).
Mapping DBLMSP and DBLMSP2 Binding Site on Human
IgM—Domain-specific monoclonal antibodies that bind the
human constant  chain (23) were incubated for 90 min with
either biotinylated human IgM or biotinylated human IgG
(used as a control) before washing and adding pentamerized,
-lactamase-tagged DBLMSP or DBLMSP2 and incubating for
a further hour. After washes, the -lactamase substrate nitro-
cefin was added at 125 g/ml, and colorimetric turnover was
measured by absorbance reading at 485 nm. Antibodies were
biotinylated using EZ-link Sulfo-NHS-LC-biotin (Pierce). Con-
struction of the homology model for the DBL domain of
DBLMSP and DBLMSP2 was done using the Phyre2 engine.
Surface Plasmon Resonance Analysis—Surface plasmon res-
onance analysis was performed on a BIAcore T100 instrument
at 37 °C in HBS-EP buffer, using streptavidin-coated sensor
chips (GE Healthcare) essentially as described (63). Briefly, 300
response units of the biotinylated Cd4 tag was used as a refer-
ence, and molar equivalents of full-length biotinylated
DBLMSP or DBLMSP2 were immobilized in query flow cells.
Increasing concentrations of purified human IgMwere injected
for 30min at 10l/min until equilibriumhad been reached, and
binding was quantified from reference-subtracted sensor-
grams. The surface was regenerated after each cycle with either
2 M NaCl for 60 s for DBLMSP, or 10 mM glycine HCl, pH 3.0,
for 20 s for DBLMSP2, and duplicate injections of the same
concentration of IgM in each experiment showed no loss of
activity between each cycle. For the binding analysis using the
DBL domains only, 500 response units of biotinylated human
IgG were immobilized as a reference, and a molar equivalent of
biotinylated human IgMwas immobilized in the query flow cell.
Each purified DBL domain was resolved by gel filtration on a
Superdex 200 Tricorn 10/600 column to remove any protein
aggregates that might interfere with the kinetic measurements.
Increasing concentrations of DBL domains were injected at 20
l/min for 2 min in each cycle until equilibrium had been
reached. The surface was regenerated after each cycle with 2 M
NaCl for 60 s, with no loss of activity. Data analysis was per-
formed using BIAcore analysis software.
Generation of Polyclonal Antibodies—A polyclonal antibody
against the SPAM fragment of DBLMSPwas generated. Briefly,
a 619-bp DNA product (corresponding to amino acids 439–
633 of DBLMSP) was amplified from 3D7 genomic DNA using
primers 348ForPET30 (5	-GGTATTGAGGGTCGCAAAG-
AATTTAAAGATAACGTTACACTTCTTAAAGC-3	) and
348revbPET30 (5	-AGAGGAGAGTTAGAGCCTTAACTT-
TGTTGTTGATTACTGAGTTCTTTTTCC-3	) and cloned
into pET-30 Xa/LIC expression vector (Novagen). Expression
plasmids were sequenced before transformation into Esche-
richia coli BL21(DE3)pLysS, and expression was induced with 1
mM isopropyl -D-thiogalactopyranoside for 4 h at 30 °C.
Recombinant DBLMSPSPAM protein was purified using
nickel-nitrilotriacetic acid affinity chromatography under non-
denaturing conditions. Purified rDBLMSPSPAM was used for
antibody production in rabbits (Harlan Laboratories Inc.) fol-
lowing standard procedures. Rabbit antibodies were subse-
quently affinity-purified using rDBLMSPSPAM coupled to
CNBr-activated Sepharose 4B (GE Healthcare) and IgG-
selected using protein G-Sepharose (Sigma-Aldrich).
Polyclonal antibodies against the full-length 3D7 form of
DBLMSP were raised in rabbits (Cambridge Research Bio-
chemicals). The full-length, His-tagged protein was produced
in mammalian cells, purified by nickel-nitrilotriacetic acid
chromatography using HisTrap column (GE Healthcare) and
injected every 2 weeks over an 11-week period with the first
injection in complete Freund’s adjuvant, and the subsequent
five injections in incomplete adjuvant. Rabbit antibodies were
subsequently affinity-purified using HiTrap protein G columns
(GE Healthcare).
Immunoreactivity Analysis—Pentamerized, normalized
-lactamase-tagged parasite proteins were incubated with
serial dilutions of purified human IgM for 90 min before being
transferred to 20g/ml purified IgG fromMalawian adults (33)
and immobilized on protein G-coated microtiter plates
(Pierce). After 60 min, the plates were washed and incubated
with nitrocefin at 125 g/ml. The incubations were performed
at room temperature, and absorbance was read at 485 nm as
described above.
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